Radiesse (P050052) Radiesse is an injectable calcium hydroxylapatite implant in
Radiesse (P050052)
Radiesse is an injectable calcium hydroxylapatite implant in the form of a gel. (Approved: 12/22/2006)
« Consumer Alert: Listeria Contamination in Raw Milk New York State | Main | FDA Commissioner Announces Important Personnel Changes U.S. Food and Drug »